Medical IP's X-ray image analysis software certified as medical device

The S.Korean company plans to expand its software lineup to include the analysis of the heart, bone and blood vessels

Medical IP's X-ray image analysis software certified as medical device
Ji-Hyun Lee 1
2023-03-08 10:38:40 bluesky@hankyung.com
Bio & Pharma

Medical IP, a South Korean medical AI company, has announced that its artificial intelligence (AI) medical image analysis software "TiSepX Lung Volumetry" has received Class 2 medical device certification from the Ministry of Food and Drug Safety.

The software calculates lung volume using chest X-rays and is the first TiSepX device to receive approval.

This is the first time that a TiSepX device, which uses AI to expand 2D X-rays into 3D images and then quantitatively analyzes organs, has been approved.

The lung volumetry device automatically analyzes lung volume data just by looking at X-rays, without the patient needing additional pulmonary function tests (PFT) or computed tomography (CT) scans. It is expected to be highly useful for diagnosing and monitoring interstitial lung disease and other similar conditions.

This certification is a significant milestone for Medical IP, which plans to expand its TiSepX lineup to include the analysis of the heart, bone and blood vessels.

Write to Ji-Hyun Lee at bluesky@hankyung.com

S.Korea's Lunit supplies breast cancer imaging solution to UAE

S.Korea's Lunit supplies breast cancer imaging solution to UAE

Lunit Insight MMG South Korean medical AI company Lunit has supplied its breast cancer imaging analysis solution — Agfa HealthCare Enterprise Imaging — to the United Arab Emirates' state-run Dubai Academic Health Corp., the company said on Thursday. The solution was developed in par

Bridge Biotherapeutics, Pinotbio develop lung cancer treatment

Bridge Biotherapeutics, Pinotbio develop lung cancer treatment

South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (ADC) for treating lung cancer, adding that they will seek candidate medicines for new ADCs over the next two years.ADCs are next-generation antibody

Lunit exports AI imaging analysis solution to Brazil

Lunit exports AI imaging analysis solution to Brazil

South Korea's medical imaging startup Lunit said on Monday it has signed a software licensing agreement with Albert Einstein Israelite Hospital in Sao Paulo, Brazil, for its Lunit Insight CXR, an artificial intelligence (AI) imaging analysis solution for chest X-rays.Einstein Hospital repres

(* comment hide *}